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INTRODUCTION
Extinction learning is an important behavioral phenomenon that allows the organism to adapt its behavior to changed situations. In extinction learning, a process which appears to be based on new inhibitive or integrative learning rather than unlearning (Bouton, 2002; Phelps, Delgado, Nearing, & LeDoux, 2004) , a new memory trace is formed that competes with the initial memory (Bouton, 2002; Quirk & Mueller, 2008) . For selecting the proper response, context consideration is crucial (for review see Rosas, Todd, & Bouton, 2013) . The context-dependency of extinction is impressively illustrated by the post-extinction phenomenon renewal, which describes the recovery of a previously extinguished response when the test context differs from the extinction context (Bouton & Bolles, 1979) . By coupling learning success to the therapeutic context, the renewal effect can constitute a major challenge for the therapy of anxiety or PTSD disorders. Thus, improvement of maladaptive learning processes as well as generalization of learned adaptive behavior to other contexts is of considerable interest to both basic and clinical researchers. Successful (fear) extinction learning and its consolidation is based on activation in a widespread brain network which comprises prefrontal cortex (PFC) as well as hippocampal and amygdalar regions (for review see Sehlmeyer et al., 2009) . Moreover, extinction learning and memory depends, among others, on glutamatergic neurotransmitter activation. N-methyl-Daspartate receptors (NMDAR) are considered a main candidate for modulating extinction learning and renewal (for review see Myers & Davis, 2002) . First evidence of NMDAR dependent extinction processes were provided by animal studies, which demonstrated significant impairments in diverse learning and memory processes induced by NMDAR blockade (Kim, DeCola, Landeira-Fernandez, & Fanselow, 1991; Xu, Russell, Bazner, & Hamilton, 2001 ; for review see Riedel et al., 2003) . Infusion of NMDAR antagonists into prefrontal brain areas also caused significant deficits in extinction and reversal learning (Bohn, Giertler, & Hauber, 2003; Lissek & Güntürkün, 2003; Quirk & Mueller, 2008) as well as in consolidation of extinction (Baker and Azorlosa, 1996; Burgos-Robles et al., 2007; Santini et al., 2001; Sotres-Bayon et al., 2009 ; for review see Davis, 2011) . Complementary to the effects of NMDAR blockade, the administration of NDMA agonists was found to enhance extinction learning and its consolidation (for review see Fitzgerald, Seemann, & Maren, 2014) . After promising results in rats, which indicated enhancing effects of the partial NMDA agonist D-Cycloserine (DCS) in fear extinction (e.g. Ledgerwood, Richardson, & Cranney, 2003; Walker, Ressler, Lu, & Davis, 2002) , researchers discovered DCS as a potential pharmacological support for exposure therapy, a therapeutic method analogous to extinction. Since then, clinical implications of pre-learning DCS administration were investigated in different patient groups, demonstrating significant beneficial effects of combined DCS / exposure treatment compared to placebo / exposure treatment. Indeed, enhancing DCS effects upon extinction were reported for patients suffering from acrophobia (Ressler, Rothbaum, Tannenbaum, & Anderson, 2004; Smits, Rosenfield, Otto, Powers, et al., 2013) , social anxiety (Hofmann, Pollack, & Otto, 2006; Smits, Rosenfield, Otto, Marques, et al., 2013) , panic (Otto et al., 2010) as well as obsessive compulsive disorder (OCD; Kushner et al., 2007; Wilhelm et al., 2008) . Nonetheless, some studies failed to find an effect of DCS in clinical populations, although statistical trends were detected (spider phobia: ; agoraphobia / panic disorder: Siegmund et al., 2011; OCD: Storch et al., 2007) . Whereas most patient studies found promising DCS pharmacotherapeutic effects upon lasting fear reduction in individuals, studies with healthy human participants are still rare and yielded contradictory results: Whereas a single dose of DCS (250 mg) enhanced declarative learning in healthy human participants (Onur et al., 2010) , no significant effects on memory tasks were observed after administration of a weekly dose of 50 mg DCS (Otto, Basden, & Mchugh, 2009 ). Likewise, inconsistent DCS effects were reported in the extinction of conditioned fear in healthy participants. While single doses of 50, 250 or 500 mg of DCS yielded no significant effects in fear extinction Klumpers et al., 2012) , a 100 mg DCS dose enhanced extinction learning (Kuriyama, Honma, Soshi, Fujii, & Kim, 2011) . The meta analysis by Rodrigues et al. (Rodrigues et al., 2014) summarizes those contrasting observations by highlighting beneficial DCS effects on human extinction learning particularly at low doses (25-250 mg). Moreover, post-learning DCS administration also revealed beneficial effects and improved extinction memory consolidation in animals (Bouton, Vurbic, & Woods, 2008; Ledgerwood, Richardson, & Cranney, 2003; Woods & Bouton, 2006) . Similar enhancements were also demonstrated in human patients suffering from acrophobia (Smits, Rosenfield, Otto, Powers, et al., 2013) . Importantly, the observed clinical improvement was moderated by the success of extinction learning: Patients who reached a low anxiety level at the end of the extinction / exposure session showed a significantly greater enhancement than patients whose anxiety levels remained high. Also non-clinical trials demonstrated enhancing effects in fear extinction memory consolidation after post-learning DCS administration, evidenced by increased skin conductance responses (Kalisch et al., 2009 ). Thus, DCS can be described as a cognitive enhancer that interacts with the extinction learning process to boost behavioral extinction and consolidation (for review see Vervliet, 2008) . In view of this therapeutic success, we here investigate the behavioral and neuronal effects of DCS on extinction learning without a fear component. Up to now, the underlying neural mechanisms have rarely been investigated. We only know from recent studies that enhanced declarative learning induced by DCS was associated with significantly increased hippocampal activation (Onur et al., 2010) . In accordance, Kalisch and colleagues (Kalisch et al., 2009) observed enhancing effects of DCS in fear memory consolidation as well as increased activation in the posterior hippocampus / collateral sulcus region and in the medial prefrontal cortex -brain regions that are known to mediate extinction and renewal (Golisch, Heba, Glaubitz, Tegenthoff, & Lissek, 2017; Lissek, Glaubitz, Güntürkün, & Tegenthoff, 2015; Lissek, Glaubitz, Schmidt-Wilcke, & Tegenthoff, 2016; Lissek, Glaubitz, Uengoer, & Tegenthoff, 2013; Lissek, Glaubitz, Wolf, & Tegenthoff, 2015) . However, to the best of our knowledge, there are no studies as yet that combine DCS and functional magnetic resonance imaging (fMRI) to explore potential effects upon the extinction-related phenomenon of renewal. Up to now, we only know that in animals, DCS reduces spontaneous recovery (Ledgerwood et al., 2003; Walker et al., 2002) as well as reinstatement (Ledgerwood, Richardson, & Cranney, 2004) , but not rapid reacquisition (Ledgerwood, Richardson, & Cranney, 2005) or renewal (Woods & Bouton, 2006 ) (for review see Vervliet, 2008) . To assess the effects of DCS upon the processing of contextual extinction learning and renewal in healthy human participants, we used an associative learning task, in which participants were required to learn relations between stimuli and outcomes presented in different contexts, which were reversed during extinction learning. This predictive learning task (Üngör & Lachnit, 2006) , which we already used in previous studies (Golisch et al., 2017; Lissek, Glaubitz, Güntürkün, & Tegenthoff, 2015; Lissek, Glaubitz, Uengoer, & Tegenthoff, 2013; Lissek, Glaubitz, Wolf, & Tegenthoff, 2015; , features an ABA design suited to evoke renewal, combined with a control AAA condition that does not evoke renewal. Healthy volunteers received a single dose of the NMDAR agonist DCS or a placebo prior to extinction learning of previously acquired associations. Based on earlier findings, we predicted that DCS would enhance extinction learning performance, relative to placebo. Furthermore, it is conceivable that a better extinction learning performance may also influence renewal rates. However, since as of today little is known about the effects of DCS on human renewal and thus a directional hypothesis cannot be derived from the literature.
Moreover, we hypothesized that the enhancement in extinction learning would be associated with increased brain activation in regions that are highly involved in context-related extinction learning and have a high density of NMDAR, such as prefrontal cortex and hippocampus.
MATERIALS AND METHODS

Participants
Fifty-two healthy right-handed volunteers (24 males, 28 females) participated in this study. Four subjects had to be excluded due to weak learning performance (i.e. overall percentage of correct responses during acquisition < 70%) or inadequate datasets, including signal or movements artifacts. All reported analyses are calculated from the final sample of 48 participants with 24 subjects per group (21 males, 27 females). Participants were randomly allocated to the experimental D-Cycloserine (DCS) or control placebo (PLAC) group; mean age within the groups was 23.79 years ± .84, range 19-35 years in DCS and 25.29 years ± .70, range 20-31 years in PLAC. All participants had normal or corrected-to-normal vision; none had any current neurological and medical condition. Subjects participated in the present study after giving written informed consent. The protocol was approved by the local ethics board of the Ruhr-University Bochum and conforms to the Code of Ethics of the World Medical Association (Declaration of Helsinki). Prior to the experiment, participants received handouts informing them about the pharmacological properties of the NMDAR agonist D-Cycloserine, its general clinical use and the fMRI procedure. The participants received a monetary compensation (in the amount of 60€).
Predictive Learning Task
The predictive learning task was similar to the task developed by Üngör and Lachnit (2006) and investigates context-dependency of associative learning and the renewal effect. It has previously been used in several behavioral (Lucke, Lachnit, Stüttgen, & Uengoer, 2014; Üngör & Lachnit, 2008) as well as fMRI studies, which successfully investigated contextdependent extinction learning (Golisch et al., 2017; Lissek, Glaubitz, Güntürkün, et al., 2015; Lissek et al., 2013; Lissek, Glaubitz, Wolf, et al., 2015; Lissek, Golisch, Glaubitz, & Tegenthoff, 2016) . The task design allows for learning of associations between stimuli and outcomes with or without encoding of the context, because regarding or ignoring the context does not impact the ability to learn the task. Moreover, the task reliably tests for renewal, since the intra-individual reproducibility of the renewal effect has recently been demonstrated (unpublished data; Golisch et al.) . In the predictive learning task, participants are asked to put themselves in the situation of a physician and predict whether their patient will suffer from stomachache after consuming diverse food items served in different restaurants. In this way, participants learn to associate several stimuli (food items) with particular consequences (occurrence or nonoccurrence of stomachache) in different contexts (restaurants). The experiment was divided into three different phases: acquisition, extinction and recall. During the task, participants learned the association between a food item and a specific consequence. In each trial of the acquisition phase (80 trials), four of eight food stimuli (fruit or vegetable; see Figure 1C ) was presented in one of two contexts. The context was indicated by the name of the restaurant ("Zum Krug / English: The Mug" or "Altes Stiftshaus / English: The Dome") and a frame in either red or blue color. The stimulus-context combination was presented for 3 seconds. Then a question asking whether the patient will suffer from stomachache, together with the response options "yes" or "no" were presented on the screen. Within 4 seconds, participants had to respond via a fMRI-ready keyboard (Lumitouch response pad, Photon Control Inc. Canada). Immediately after their response, or in case of a missing response at the end of the response period, the feedback with the correct answer was presented for 2 seconds: "The patient has a stomachache" (written in red color) or "The patient does not have a stomachache" (written in green color; see Figure 1A ). The food stimuli were presented in randomized order; each stimulus was presented 10 times. Four stimuli were presented per context. Stimuli were counter-balanced with regard to their causing the aversive consequence of a stomachache, with two stimuli per context causing stomachache during acquisition, whereas the other two did not. The order of trial types was randomized between participants. In the extinction phase (80 trials), half of the stimuli were presented in the same context as during acquisition (AAA condition, 40 trials), while for the other half of the stimuli the context changed (ABA condition, 40 trials) (see Figure 1B ). Both conditions were performed by all participants. Furthermore, stimuli were subdivided into two types: First, the actual extinction trials, where the consequence of stomach trouble changed and the new consequence had to be learned and second, the control trials, where the consequence did not change. The latter were introduced in order to make the overall learning more complex and therefore difficult. In each context a consequence change was present in two stimuli (CC), while it was absent in the two control stimuli (nonCC). All other aspects of the extinction phase were identical to those of the acquisition phase. During the recall phase (40 trials), all stimuli were again presented in the context of acquisition (five presentations of each stimulus-context combination), whereupon no feedback was given. No further aspects were changed compared to the acquisition phase.
Figure 1. Predictive learning task. A)
Example trial of a learning phase during the predictive learning task. Participants learned the association between a food item, eaten in a specific restaurant, and a specific consequence. After an intertrial interval of 5-9 s the stimulus and its context was presented for 3 s. Then the question was posed, whether the patient will suffer from stomachache including a response time of max. 4 s. A feedback, providing the correct answer, was presented for 2 s. B) The predictive learning task consists of three learning phases: acquisition, extinction and recall. In the AAA condition, all phases occur in the same context, while in the ABA condition the extinction context differs. In both conditions, the recall phase is identical to the acquisition phase to test for renewal. C) Food images used in the paradigm.
Procedure
Two separate MR sessions comprising structural and functional imaging were conducted on a single day. In the first session, a structural T1-weighed image was recorded, after which participants completed the acquisition phase of the predictive learning task. Subsequently, half of the participants received a single oral dose of 125 mg DCS, while the other half received an identical-looking placebo and acted as a control group. After drug administration, participants rested for 1.5 h, after which the second fMRI session, comprising extinction learning and recall phases, was performed. The timing was based on the pharmacological profile of DCS and its time to peak (Baron, Epstein, Mulinos, & Nair, 1956 ). Thus, the study duration was about 3 h in total.
Imaging data acquisition
Structural and functional imaging was performed on a whole-body 3.0 Tesla magnetic resonance tomography scanner (Philips Achieva 3.0 T X-Series, Philips, The Netherlands) with a 32-channel SENSE head coil. Using an isotropic T1-weighted TFE sequence (TR 8.2 ms, TE 3.7 ms, field of view 240 mm, slice thickness 1 mm, 220 transversal slices with a voxel size of 1 x 1 x 1 mm 3 ), high resolution structural brain images were acquired for each participant. For the functional analysis, blood-oxygen level dependent (BOLD) contrast images were acquired with a dynamic T2*-weighted EPI-sequence (TR 3200 ms, TE 35 ms, flip angle 90°, field of view 224 mm, slice thickness 3 mm, 45 transaxial slices parallel to the anterior commissure-posterior commissure (AC-PC) plane with a voxel size of 2 x 2 x 3 mm 3 ). The task was presented to participants via fMRI-ready LCD-goggles (VisuaStim Digital, Resonance Technology Inc., Northridge, CA, USA) connected to a laptop that supported a specific software programmed in Matlab. Responses were reported via an fMRI-ready keyboard (Lumitouch response pad, Photon Control Inc., Canada).
Imaging data analysis
For preprocessing and statistical analysis of fMRI data we used the software Statistical Parametric Mapping (SPM), Version 8 (Wellcome Department of Cognitive Neurology, London, UK), implemented in Matlab R2008a (The Mathworks, Natick, MA, USA). Three dummy scans, during which BOLD signal reached steady state, preceded the actual data acquisition of each session, thus preprocessing started with the first acquired volume. Preprocessing on single subject level consisted of the following steps: slice timing correction to account for time differences due to multislice image acquisition; realignment of all volumes to the first volume for motion correction; spatial normalization into standard stereotactic coordinates with 2 × 2 × 2 mm 3 using an EPI template of the Montreal Neurological Institute (MNI), smoothing with a 6 mm full-width half-maximum (FWHM) kernel, in accordance with the standard SPM procedure. The acceptable limit for head motion was 2 mm for translational movements and 0.5° for rotational movements. In a first level single subject analysis, we calculated activation during extinction and recall phases in the conditions ABA and AAA, respectively. The contrasts were calculated within a combined anatomically defined mask which was constructed using the software MARINA (BION Bender Institute of Neuroimaging, University of Giessen, Germany) (Walter et al., 2003) . The mask consisted of a priori regions of interest, containing bilateral prefrontal cortex, hippocampus, amygdala, insula, and temporal lobe. All data contained in this combined mask were analyzed together in a single analysis. We used an event-related design, modeling the events of each trial (AAA and ABA, extinction and control trials), i.e. onsets of stimulus, question and feedback presentation, as stick functions convolved with the SPM default hemodynamic response function (HRF) in SPM (i.e. as delta functions with a duration of 0 seconds). Our analyses were based on the stimulus presentation phase of each trial. These contrast images were entered into second-level random-effects analyses. In one-sample tests we analyzed the activation patterns of the experimental and control groups for the different contrasts, using a threshold of p<.05 FWE-corrected on voxel level with a minimal cluster size (k) of 10 voxels (k=10), adding age and gender as nuisance variables. Moreover, we calculated two-sample tests (again with age and gender as nuisance variables) to directly investigate in which regions the experimental group showed differential activation compared to controls (p<.05 FWE-corrected on cluster level, k=10). For all reported analyses peak coordinates and related t-and p-values as well as cluster sizes are reported in corresponding tables (see Table 1 -3).
Behavioral data analysis
For all three learning phases, recorded log files contained information on response latency, response type and correctness of response, from which we calculated error rates. Errors in acquisition and extinction learning were defined as responses stating the incorrect association between the stimulus-context compound and the consequence. For calculation of the renewal effect, only responses to stimuli with a consequence change during the recall phase were analyzed. The behavioral renewal effect in the predictive learning task is supposed to occur only in the condition ABA, in which extinction is performed in a context different from the context present during acquisition and recall phase. During recall, a renewal effect occurs if a response is given that was correct during acquisition, but wrong during extinction (e.g. if during acquisition cherries in context A cause stomachache, and during extinction cherries in context B do not cause stomachache any more, then a renewal effect response during recall states that cherries in context A cause stomachache). Statistical analyses (t-tests, ANOVA, ² and correlations) were performed using the IBM SPSS Statistics for Windows software package, version 23.0 (IBM Corp, Armonk, NY, USA). To test our hypotheses, we used twotailed t-tests. In case of a necessary Greenhouse-Geisser correction, the  value is added to the corresponding ANOVA results. All results are quoted as mean ± SEM, unless stated otherwise.
RESULTS
Behavioral Results
Extinction Learning -As predicted, the repeated measures ANOVA yielded a trend towards a significant main effect of the factor treatment (DCS vs. PLAC; F(1, 46)=3.764, p=.059) , while the factor extinction condition (AAA CC vs. ABA CC; F(1,46)=.00, p=1.00) as well as the interaction extinction condition*treatment (F(1,46)=1.907, p=.174) showed no significant effects. These results reflect potential learning differences between both groups, which are focused in the subsequent analyses.
As predicted, we observed extinction learning enhancements in the DCS group. For overall extinction learning performance there was a trend towards a significant group difference in terms of extinction errors (all CC) (t(46)=-1.940, p=.059; percent errors mean: DCS 12.92% ± 1.32, PLAC 17.29% ± 1.83). When considering only extinction trials in an identical context (AAA condition), DCS participants showed a significantly better learning performance in comparison to PLAC participants (t(46)=-2.937, p=.005; DCS 12.08 ± 1.34, PLAC 18.13 ± 1.56). However, no significant group differences were observed in extinction trials in a novel context (ABA condition) (t(46)=-.910, p=.367; DCS 13.75 ± 1.68, PLAC 16.46 ± 2.45). (See Figure 2A.) To analyze the learning progress over time, we divided the learning session into 8 blocks with 10 trials each and calculated the percentage of AAA and ABA extinction errors separately for each of these blocks. In AAA extinction learning, a repeated measures ANOVA showed a significant main effect of the factor learning block upon error rates (F(7,322)=61.787, p<.001; =.665) and a significant interaction of learning block*treatment (F(7,322)=3.331, p=.002; =.665), indicating that the learning progress differed between the DCS and PLAC group. However, no significant main effect of the factor treatment was observed (F(1,46) Figure 2C .) For ABA extinction learning, the repeated measures ANOVA yielded a significant main effect of the factor learning block upon error rates (F(7,322)=37.606, p<.001; =.592), while the interaction learning block*treatment (F(7,322)=.350, p=.930; =.665) as well as the factor treatment (F(1,46)=.205, p=.653) showed no significant effect. These results reflect a comparable learning progress in ABA extinction for DCS and PLAC participants. (See Figure  2D .) DCS and PLAC participants did not differ in their reaction times during extinction learning (t(46)=.796, p=.430; DCS 659 ms ± 44, PLAC 607 ms ± 47). Moreover, no group differences were present in pre-treatment acquisition of the original stimulus-outcome associations in terms of the percentage of errors made during acquisition (t(46)=-1.454, p=.153; DCS 9.90 ± 1.25, PLAC 12.60 ± 1.38). Since we administered a fixed dose of DCS without consideration of participants' BMI, we checked for a potential dose-dependent mode of action by correlating participants' BMI with their extinction error rates. The null result (Pearson r=-.041, p=.849) disproves the assumption of a dose-dependent effect.
Renewal Effect -Both groups retrieved associations correct during acquisition significantly more frequently in ABA recall, where extinction occurred in a different context, than in AAA recall, where the context was identical in all learning phases (t(47)=-3.969, p<.001; ABA 22.71 ± 5.02, AAA 2.92 ± 1.23), indicating that both showed ABA renewal together with unimpaired retrieval of AAA extinction memory. However, with 22.50% (± 7.23) renewal responses (i.e. percentage of responses that were correct during acquisition) in the PLAC group and 22.92% (± 7.11) in the DCS group, the groups did not differ in their level of renewal (t(46)=.041, p=.967). Also, in AAA recall trials no significant group differences were observed (t(46)=1.020, p=.313; DCS 4.17 ± 2.33, PLAC 1.67 ± .78). (See Figure 2B. ) In both groups, those participants who showed (REN) or did not show the renewal effect (NoREN) were equally distributed (DCS ²=2.667, p=.102, REN=33.3%, NoREN=66.6%; PLAC ²=2.667, p=.102, REN=33.3%, NoREN=66.6%). Also, REN subgroups did not differ significantly with regard to the strength of the renewal effect (t(14)=.000, p=1.00), with DCS and PLAC participants showing the similar mean of renewal responses (percent renewal responses mean: DCS 65.0% ± 10.69, PLAC 65.0% ± 11.18). 
Imaging Results
To determine brain activation patterns during extinction and recall phases in identical (AAA) or novel contexts (ABA) for PLAC and DCS participants, we analyzed the data separately for each group, including age and gender as nuisance variables. In subsequent two-sample t-tests, we directly investigated the effects of DCS on brain activation during extinction learning and recall compared to PLAC participants.
Activation patterns during extinction learning and recall -for DCS and PLAC groups separately
Extinction learning -During extinction learning in an identical context (AAA condition), both groups showed activation in putamen, insula (BA 13 and 47) and parahippocampal as well as lingual gyrus (BA 19 and 30). Moreover, both groups exhibited activation in dlPFC (BA 9, 45 and 46), OFC (BA 10 and 47) and superior temporal gyrus (STG; BA 22, 38 and 41). Additional activation in thalamus, hippocampus, fusiform gyrus as well as amygdala was only observed in PLAC participants. In right hemispheric prefrontal brain areas, however, DCS participants exhibited prominent activation clusters compared to PLAC participants.
During extinction learning in a novel context (ABA condition) similar brain activation was observed for the PLAC group, whereas DCS participants showed reduced activation patterns predominantly in OFC, dlPFC and insula. Thus, the overlay of activation patterns for AAA and ABA extinction demonstrates a more extended as well as denser activation network in condition AAA particularly for the DCS group, whereas similar patterns were observed in PLAC participants (see Table 1 and Figure 3 ).
Recall -During extinction recall, where all stimuli were again presented in the context of acquisition, both groups showed prominent activation clusters in dlPFC (BA 8, 9, 44) and insular regions (BA 13 and 47) as well as in fusiform (BA 20 and 37) and cingulate gyrus. In addition, the DCS group exhibited activation clusters in OFC (BA 10 and 47) and in STG (BA 22), where PLAC participants showed only little activation. The difference in activation was particularly prominent in condition AAA (see Table 2 ). 
Effects of DCS on brain activation during extinction learning and recall -a comparison to PLAC participants
Extinction learning -Since we observed an enhancement on behavioral as well as on brain activation level in DCS participants in AAA but not in ABA extinction, we conducted further direct group comparisons to highlight potential activation differences in extinction-relevant regions that account for a better AAA extinction performance in the DCS group. In order to eliminate spurious activations from perception, motor activity and attention that are common in both conditions, we considered both (groups and conditions) in one contrast. When contrasting condition AAA and ABA in a two-sample t-test (DCS > PLAC, AAA > ABA), DCS participants in comparison to PLAC showed increased activation in various brain regions including dlPFC (BA 8, 9 and 44), OFC (BA 10 and 47), STG (BA 22, 38 and 41), hippocampus, insula as well as fusiform and lingual gyrus (see Table 3 and Figure 4 ). The reversed contrast did not yield any significant group differences, indicating that PLAC participants did not exhibit higher activation than DCS when contrasting AAA and ABA extinction learning.
Recall -The two-sample t-tests did not yield any significant activation differences between both groups in AAA and ABA recall. 
DISCUSSION
In this study, we investigated the influence of the NMDA system on extinction learning in changed and identical contexts as well as on the renewal effect. While a single dose of the NMDAR agonist DCS significantly reduced extinction errors in the acquisition context, compared to PLAC, it affected neither extinction learning in novel contexts, nor the renewal effect. In line, faster extinction learning occurred in condition AAA, indicating that adapting an established stimulus-outcome association in identical contexts was easier for DCS participants. Imaging results, comparing AAA and ABA extinction, revealed higher brain activation in DCS than in PLAC participants in various extinction-related brain regions.
Results indicate differential recruitment of resources for AAA and ABA extinction learning.
DCS improves extinction learning in identical but not in novel contexts
In line with our hypothesis, we observed extinction learning improvements in the DCS group: DCS participants showed significantly better and faster extinction learning performance in condition AAA than PLAC, whereas no significant differences were observed in ABA extinction. Thus, adapting an existing association to a novel outcome was significantly facilitated by NMDA agonism if this learning took place in an identical context. The involvement of NMDAR in AAA extinction was recently demonstrated in our previous fMRI study (Golisch et al., 2017) , where the same predictive learning task was used. Here, the NMDAR antagonist memantine also enhanced AAA extinction, which in turn was associated with memantine's potential dose-dependent mode of action. Interestingly, again the NMDAR modulation did neither facilitate nor impair extinction in a novel context (ABA extinction). A similar result was recently observed in a rodent study. Here, André and colleagues (André, Güntürkün, & Manahan-Vaughan, 2015 ) also demonstrated differential effects of an mGlu5 antagonist in AAA and ABA extinction: Whereas extinction learning of the consolidated context was impaired (AAA), learning of a new context (ABA) was unaffected. Furthermore, these results complement animal studies that found prefrontal NMDAR antagonism causing increased perseveration on previously established associations (Lissek, Diekamp, & Güntürkün, 2002; Lissek & Güntürkün, 2003) . Conceivably, processing of AAA and ABA extinction learning requires differential involvement of glutamatergic stimulation in extinction-relevant regions. In AAA extinction learning, the same stimulus-context compound is subsequently being related to two different outcomes. The uncoupling of this compound from its initial outcome and its coupling to the new outcome, as well as response selection from these competing memory traces, may require a higher, NMDAR-mediated level of behavioral flexibility, so that the NMDA agonist offered a processing advantage. In contrast, in ABA extinction learning, the relation of a stimulus to two different contexts during acquisition and extinction, respectively, presumably induces the formation of two distinguishable memory traces, each comprising a different contextstimulus-outcome association. Such a coexistence of memory traces might require less NMDAR-mediated behavioral flexibility and therefore did not benefit from administration of the NMDA agonist.
Overall, the present results are in line with previous literature in humans (Hofmann et al., 2006; Onur et al., 2010; Otto et al., 2010; Ressler et al., 2004; Smits, Rosenfield, Otto, Marques, et al., 2013; Wilhelm et al., 2008) and animals (Ledgerwood et al., 2003; Walker et al., 2002;  for review see Fitzgerald et al., 2014) and extend those findings to non-fear related extinction learning.
Enhanced extinction learning is associated with increased activation in task-relevant brain regions
In line with the observed behavioral learning improvements, the DCS group showed higher activation than PLAC in frontal (dlPFC, OFC, ACC), temporal (STG) and limbic structures (hippocampus, insula) as well as fusiform and lingual gyrus during AAA compared to ABA extinction. Activation of this complex extinction network was already observed in many fMRI studies (e.g. Lissek, Glaubitz, Güntürkün, et al., 2015; Lissek, Glaubitz, Wolf, et al., 2015; Sehlmeyer et al., 2009 ), while our study demonstrates the involvement of the NMDA system in these regions in contextual associative learning. By reporting observed increased activation in various brain areas, especially dlPFC and OFC, which are relevant for higher cognition, cognitive control and attention, we support the notion that DCS is often discussed as a cognitive enhancer (for review see Vervliet, 2008 ). Up to now, studies investigating the effects of DCS on prefrontal activation are still rare. However, a previous fMRI study demonstrated enhancing DCS effects on fear memory consolidation, which were also associated with increased mPFC activation (Kalisch et al., 2009 ). Likewise, a recent animal study indicated that DCS infusions into mPFC facilitated re-extinction of fear in rats, whereas no significant effects were observed during extinction (Chang & Maren, 2011) . Moreover, the present findings complement previous work of our laboratory, in which the blockade of NMDAR in turn caused reduced activation during extinction especially in dlPFC and OFC (Golisch et al., 2017) . Thus, despite their small number, these studies already hint at significant NMDAR modulation of prefrontal processing that might be associated with (extinction) learning and memory -a finding corroborated by our present study.
In accordance with the increase in hippocampal activation in DCS-treated participants observed here, Onur and colleagues (Onur et al., 2010) reported significantly higher hippocampus activation together with facilitating DCS effects in declarative learning in healthy humans. Likewise, enhancing effects of DCS on fear memory consolidation were also found associated with increased neural responses in left posterior hippocampus and in the collateral sulcus region as well as in the prefrontal cortex (mPFC, ACC) (Kalisch et al., 2009) . Converging findings thus underline the specific modulation of hippocampal NMDAR during extinction, possibly achieved by the dynamic organization of the hippocampus that increases efficiency in input processing (Tovar & Westbrook, 2002) . Hence, hippocampal NMDAR appear to play a key role in successful extinction learning and its consolidation. In addition to a significant hippocampal involvement, our results further show the contribution of the NMDAergic system within a network of brain regions very similar to that observed in fear extinction (for review see Herry et al., 2010) , including structures of the limbic system that showed considerably increased activation during this non-fear related extinction learning paradigm. For example, insula activation is also a core finding in fear extinction studies (for review see Sehlmeyer et al., 2009 ) as well as in reversal learning (D'Cruz, Ragozzino, Mosconi, Pavuluri, & Sweeney, 2011; Ghahremani, Monterosso, Jentsch, Bilder, & Poldrack, 2010) and affective switching (Remijnse, Nielen, Uylings, & Veltman, 2005) . These findings of insula participation in behavioral flexibility underline the postulated integrative role of this structure, which may constitute a link between diverse functional systems (Kurth, Zilles, Fox, Laird, & Eickhoff, 2010) by supporting attentional, working memory and higher-order control processes (for review see Menon & Uddin, 2010) . Moreover, the activation of insular cortex is also understood to reflect uncertainty about the occurrence of an aversive stimulus (Dunsmoor, Bandettini, & Knight, 2007; Volz, Schubotz, & Von Cramon, 2003) . In our study, the uncertainty of an outcome seems to be particularly high in condition AAA, where the context cannot be used as a hint for the correct response, whereas in condition ABA the change in outcome can be associated with the context change. Consistent with this approach, we observed prominent insula activation in condition AAA that was enhanced by DCS.
In addition to insular cortex, ACC is also part of the common core network for human aversive conditioning (Büchel & Dolan, 2000) as well as for reversal learning (Kringelbach & Rolls, 2003) participating in error-monitoring and evaluative processes (Botvinick, Cohen, & Carter, 2004; Bush et al., 2002) . Our present observation of a more prominent ACC activation in DCS than in PLAC participants suggests enhancing effects of DCS upon response selection and cognitive control.
DCS has no effect on renewal We did not observe any significant effects of a pre-extinction DCS administration on ABA recall, during which participants were still drug-treated. In both groups, the same proportion of participants showed renewal, with similar overall rates of renewal. Furthermore, no significant brain activation differences between the DCS-treated and untreated participants were observed during extinction recall -neither in condition AAA nor in ABA, suggesting that the recall of previously established associations was not affected by NMDA agonism. Our results are in line with previous animal studies that did not observe any significant effects of DCS upon renewal (Woods & Bouton, 2006 ) (for review see Vervliet, 2008) . According to Woods and Bouton it can be concluded that while DCS can indeed facilitate extinction learning, the lack of an effect on renewal suggests that DCS does not destroy the original (fear) memory trace. While, human studies on the acute effects of DCS on renewal are still lacking, studies that used an NMDAR antagonist like ketamine or memantine also found no significant effects of NMDAR blockade upon renewal (Golisch et al., 2017) or retrieval of previously learned words or rules (Hetem, Danion, Diemunsch, & Brandt, 2000; Krystal et al., 2000; Rowland et al., 2005) . Thus, our results are in line with former findings supporting the conclusion that NMDAR are not necessarily involved in the recall of previously learned associations.
Clinical relevance
Previous studies demonstrated that both pre-and post-session administration of DCS can improve exposure therapy in different anxiety disorders (Hofmann et al., 2006; Kushner et al., 2007; Otto et al., 2010; Ressler et al., 2004; Smits, Rosenfield, Otto, Marques, et al., 2013; Smits, Rosenfield, Otto, Powers, et al., 2013; Wilhelm et al., 2008) as well as fear extinction learning in healthy humans (Kalisch et al., 2009) , which is analogous to exposure therapy. Our present study corroborates the previous results and moreover, demonstrates that the enhancing effect of DCS upon learning performance is not restricted to fear extinction, but is also present in extinction learning without a fear component, and therefore appears to have a general role in learning-related neuronal plasticity. Hence, our results highlight the high validity of DCS effects upon extinction learning in general, and in addition suggest that DCS may also be useful in the therapy of unwanted behaviors that are not related to fear. Thus, it is conceivable that DCS may lead to psychopharmacotherapeutic benefits also in cognitive therapy. In line with previous DCS application in exposure therapy, the present results thus encourage the implementation of pre-session DCS administration in cognitive therapy in order to facilitate the adaptation of patients' maladaptive cognitive strategies. More research is necessary to validate this promising approach in patients and moreover to identify the most appropriate dosage of DCS.
SUMMARY
In this study we investigated the role of NMDAR for context-related associative extinction learning and renewal in healthy human participants. Pre-extinction-learning administration of the NMDAR agonist DCS led to a significantly faster and less error-prone extinction learning progress, compared to PLAC participants, in trials where extinction took place in a context identical to acquisition (AAA), but not in a novel context (ABA). This selective performance improvement was accompanied by higher activation in prefrontal (dlPFC, OFC, ACC) and temporal (STG) as well as in hippocampal / insular regions in AAA compared to ABA extinction. In contrast, DCS did not affect recall of previously established associations, and thus did not alter renewal levels. In summary, we have presented evidence suggesting specific involvement of NMDAR located in components of the extinction network in human extinction learning, particularly in readjusting the stimulus-outcome relationship against the background of an identical context. Thus, our results support the assumption of DCS acting as a cognitive enhancer, with a potential to support psychotherapy of unwanted behaviorsalthough contextual conditions have to be taken into account.
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